This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

Supervisory Board

Udo J. Vetter

Chairman of the Board

Udo was appointed chairman of the Supervisory Board in March 2007, succeeding ITM co-founder Dr Maurits Geerlings. As a US-trained pharmacist, Udo has served as Managing Director of various leading pharmaceutical companies throughout his entrepreneurial career and also represents UV-Cap GmbH & Co KG, investor of the ITM. In addition, Udo serves as chairman and member of supervisory and advisory boards of several innovative companies and institutions and is also a member of the International Leadership Forum of the International Society of Pharmaceutical Engineering (ISPE).

Oliver Buck

Oliver is a bio-physicist by education who has spent his professional career in a variety of entrepreneurial and management positions in industrial companies. Since January 2005, Oliver has devoted his time and expertise to the development of ITM Isotopen Technologien München AG as its Chief Executive Officer. His main angle has been the development of ITM Group's corporate and strategic alignment and its product pipeline. As of April 2012, Oliver actively continues to support the ITM Group in its strategic and global market development as senior advisor to the CEO.

Michael Lee-Chin

Michael Lee-Chin joined the supervisory board in May 2019. Mr. Lee-Chin is founder and chairman of Portland Holdings, a privately held investment company headquartered in Burlington, Ontario, Canada. The company is committed to investing in businesses active in strong, long-term growth industries that also seek to improve the social well-being of the communities in which they operate. The philosophy of Michael Lee-Chin and Portland Holdings is to “do well and do good” – building strong businesses that are giving back to society. For his entrepreneurial and philanthropic work, Mr. Lee-Chin has received numerous awards and honors.

Dr Bent Reichardt

Bent studied Business Administration and Economics focusing on Finance and Strategy. He holds a PhD and MBA from University of St. Gallen, as well as Mphil from London Business School. During his professional career he acquired significant experience in developing and transforming companies in start-up, growth and turn-around situations. Today, Bent is Managing Director at Deutsche Invest Equity Partners GmbH.

Manuel Salvisberg

Manuel Salvisberg holds an MA in finance from University of St. Gallen and Fudan University in Shanghai. He is a also CFA and CAIA charterholder. After having worked for The Boston Consulting Group and a private equity firm, Manuel has structured and now runs the investments of Dr. Uli Sigg, the former Swiss ambassador to China. Manuel sits on numerous boards of directors of technology and financial services companies.

Gunther Strothe 

Gunther obtained an MA in Economics and an MBA. Previously, Gunther held several managing functions such as CFO of Hugo Boss AG, Investment Banking at Goldman Sachs, and Managing Director Germany at Oliver Wyman & Company. Moreover, he is a non executive member of several boards since 1996. Gunther became a member of ITM´s supervisory board in 2016.